FDA-approved treatments for spinal muscular atrophy differ in their mechanisms of action, safety profiles, and administration ...

Panelists discuss how clinicians should interpret Clinical Dementia Rating-Sum of Boxes (CDR-SB) score changes by correlating ...

Panelists discuss how amyloid-targeting therapies for Alzheimer disease represent a breakthrough drug class that works by ...

National Infertility Awareness Week highlights that infertility impacts both men and women, is more prevalent among Black and ...

Accessing equitable health care is an ongoing struggle in the US for minority communities due to historical pretexts with new ...

Panelists discuss how uncomplicated urinary tract infections (UTIs) are typically managed with empiric short-course ...

Experts discuss how current coverage policies and prior authorization requirements affect continuous glucose monitoring (CGM) access and adoption rates, and how coverage barriers impact the ability to ...

Inebilizumab-cdon (Uplizna; Amgen) was approved as the first and only treatment for immunoglobulin G4–related disease ...

The West Health-Gallup Healthcare Indices Study indicates that approximately 29 million people are unable to afford or access ...

New findings may help patients with low to moderate risk of tumor lysis syndrome while reducing the burden for hematologists.

Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...

In a series of interviews, experts highlight lasting health care innovations that emerged during the COVID-19 pandemic, including telemedicine, artificial intelligence (AI), and home-based treatment.